But as we've noted above drug repurposing is usually done by accident or in a moment of great desperation, such as the COVID-19 pandemic
semaglutide in the US around 2031) will further expand demand for generic/biosimilar API, and CDMOs are gearing up (increasing vessel size, procuring large chromatography columns) to produce those large-volume, high-purity lots ( [19] )
Tirzepatide: Another Relevant Comparison Tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 agonist approved by the FDA, provides another useful reference point
Key potential benefits include improved satiety after meals, a smoother energy curve, and a contributing role in a normal lipid metabolism through the choline content
Why Personalized Medicine Depends on Compounding Personalized medicine pharmacy models rely entirely on this level of customization
Gradual, natural improvement